About Cibus
Cibus is a publicly listed company based in San Diego (United States) founded in 2001 by Peter Beetham and Rory Riggs. Gene editing solutions are provided for agriculture. It operates on a AgriTech Models model. Cibus has raised $34.47 million across 13 funding rounds from investors including Fidelity Investments, ADAMA and Qubis. The company has 159 employees. Its chief executive, as recorded, is Peter Beetham. Cibus offers products and services including Stronger Seeds, Precision Breeding, and Sustainable Ingredients. Its focus areas include Biotechnology and Crop Enhancement. Its legal entity is Cibus Inc. Its competitors include Benson Hill, Pairwise and Inari; 3 of its 3 listed competitors have raised funding.
Company details
Cibus is engaged in agricultural biotechnology, specializing in precision breeding to develop more resilient, sustainable, and vigorous crops. The company operates within the agriculture sector, focusing on crop enhancement solutions that reduce the need for chemicals and energy. Proprietary technologies are utilized to create crops with specific traits, addressing challenges like heat, pests, and disease. Partnerships with agricultural entities are maintained to deliver tailored seed solutions, contributing to a healthier planet through sustainable food production.
- Annual Revenue$3.64 M (USD)-14.62as on Dec 31, 2025
- Net Profit-$127.08 M (USD)49.45as on Dec 31, 2025
- EBITDA-$61.54 M (USD)12.22as on Dec 31, 2025
- Total Equity Funding$34.47M (USD)
in 13 rounds
- Latest Funding Round$701.83K (USD), Post-IPO
Apr 2020
- InvestorsFidelity Investments
& 4 more
- Employee Count159
Products & Services of Cibus
Cibus offers a comprehensive portfolio of products and services, including Stronger Seeds, Precision Breeding, and Sustainable Ingredients.
Seeds are developed for resilience and sustainable crop growth.
Crops are engineered for vigor and environmental adaptability.
Ingredients are created for eco-friendly agricultural product use.
Funding Insights of Cibus
Cibus has successfully raised a total of $34.47M across 13 strategic funding rounds. The most recent funding activity was a Post-IPO round of $701.83 thousand completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.47M
- Total Rounds 13
- Last Round Post-IPO — $701,834
- Investors Count 5
Latest 10 of 13 funding rounds of Cibus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2020 | $701,834 | Post-IPO | – | Qubis | – |
| Jun 2018 | $70M | Post-IPO | – | Fidelity Investments | |
| Nov 2017 | $19.12M | Post-IPO | – | – | – |
| Jul 2017 | $57.03M | Post-IPO | – | – | – |
| May 2015 | $4.25M | Debt – Conventional | – | – | – |
| Apr 2015 | $13.5M | Series B | – | – | – |
| Aug 2014 | $4M | Debt – Conventional | – | – | – |
| Jan 2014 | $13.6M | Series B | – | – | – |
| May 2012 | $99,980 | Grant | – | – | |
| Jan 2012 | $2.06M | Series A | – | – | – |
5 investors in total: 5 institutional.
Investors in Cibus
Cibus has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, ADAMA and Qubis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Qubis is engaged in commercializing academic research from Queen's University. | qubis.co.uk | Belfast, United Kingdom | ||
Early stage investments focused VC firm | acks.com | |||
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
ADAMA is recognized as a global crop protection leader. | 1945 | adama.com | Tel Aviv, Israel | |
| usda.gov |
Investor details for Cibus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cibus
51 people are tracked at Cibus (20 in leadership, 5 in board & advisors, 26 in team); the tracked headcount is 159.
| Name | Role | Group |
|---|---|---|
Peter Beetham | Co-Founder & CEO | Leadership |
Rory Riggs | Co-Founder & CEO | Leadership |
Matt McColm | Head of IT & IS | Leadership |
David Kendra | Executive Director, Disease Trait Development | Leadership |
Greg Gocal | Co-Founder & Chief Scientific Officer & EVP | Leadership |
Sherri Kruger | Execitive Director, Production Core & Quality | Leadership |
Sean O'Connor | SVP, Cibus, President & CEO, Nucelis | Leadership |
Vanessa Tian-Vervaet | Director, Fp&a | Leadership |
Pankaj Soni | Senior Director, Molecular Discovery | Leadership |
Jason Stokes | Chief Legal Officer, General Counsel & Corporate Secretary | Leadership |
Stacy Leppert | Executive Director, Human Resources | Leadership |
Steven Sanders | Executive Director Of Molecular & Computational Biology | Leadership |
Peter Luginbühl | Director, Computational Biology | Leadership |
Carlo Broos | Chief Financial Officer | Leadership |
Shujun Chang | Associate Director, Cell Biology | Leadership |
Dolendro Nameirakpam | Associate Director- Cell Biology | Leadership |
Kaustubh Borah | Senior Director Product Management Rice And Sustainable Ingredients | Leadership |
Kelly Scarbel | Director Of Corporate Accounting | Leadership |
Kathryn Davis | Senior Director, Regulatory Affairs | Leadership |
Satyendra Rajguru | Associate Director | Leadership |
31 more people are available in the full profile.
Complete people profiles for Cibus
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Cibus
Cibus is a publicly listed company on the NASDAQ with ticker symbol CBUS in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jul 2017
- Listed onNASDAQ: CBUS
- Listed entityCibus, Inc.
- Exchange sectorTechnology services
- ISINUS17166A1016
- Share price$1.41 (-4.73% on the day) · 2026-10-13
- Market capitalisation$107.8M
- EPS (diluted, trailing year)$-1.65
- Volume (last session)45,277
Financials of Cibus
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $3.6M | -$127.1M | -$61.5M |
| 2024 | $4.3M | -$251.4M | -$70.1M |
| 2023 | $1.8M | -$267.6M | -$64.8M |
| 2022 | $157,000 | -$16.9M | -$20.8M |
| 2021 | $26.0M | -$29.2M | -$27.0M |
Detailed financial statements for Cibus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cibus
4 dated milestones of Cibus across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Cibus is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $702K.
Competitors of Cibus
Cibus has 3 listed competitors in our database, 3 of them funded. They include Benson Hill, Pairwise and Inari.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| pairwise.com | 2017 | Durham, United States | $155M | New crop varieties are developed using gene-editing for agrigenomics. | ||
| inari.com | 2016 | Cambridge, United States | $708M | 143 | Breeding technology is provided by Inari to design seeds. |
Detailed competitors of Cibus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cibus
The website of Cibus (cibus.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▲ 31.2% vs previous month
Top companies in Crop Tech & Equipment
3 companies that operate in the same segment as Cibus (Crop Tech & Equipment) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of plant-based food ingredients | 2012 | St. Louis, Missouri, United States | USD 406.99 M | USD 470 M | ||
Robotic equipment for automating weeding on vegetable farms is developed. | 2016 | San Francisco, California, United States | USD 139.96 M | 73 | ||
Provider of farmers networking platform | 2014 | San Carlos, California, United States | USD 981.09 M | 808 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cibus
Complete news archive for Cibus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cibus
Cibus was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Cibus is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Peter Beetham is the CEO of Cibus, as recorded in our data. They have also founded this company.
Cibus is a funded company, having raised a total of $34.47M across 13 funding rounds to date. The company's 1st funding round was a Series A of $2.06M, raised on Sep 2009.
Cibus has 159 employees.
Annual revenue of Cibus is $3.64M as on Dec 31, 2025.
Cibus is engaged in agricultural biotechnology, specializing in precision breeding to develop more resilient, sustainable, and vigorous crops. The company operates within the agriculture sector, focusing on crop enhancement solutions that reduce the need for chemicals and energy. Proprietary technologies are utilized to create crops with specific traits, addressing challenges like heat, pests, and disease. Partnerships with agricultural entities are maintained to deliver tailored seed solutions, contributing to a healthier planet through sustainable food production.
Cibus's top competitors include Benson Hill, Inari and Pairwise.
Cibus offers Stronger Seeds, Precision Breeding, and Sustainable Ingredients.
Yes, Cibus is publicly traded on NASDAQ under the ticker symbol CBUS.
Cibus has 5 investors. Key investors include Fidelity Investments, ADAMA, Qubis, Acks, and United States Department of Agriculture.
Cibus operates through Cibus Inc..